Valion Bio, Inc. Common Stock (VBIO) News

Latest headlines that mention VBIO, newest first · each headline opens the original publisher

VBIO quote

Last price: $0.84
Day change: -10.64%
Next earnings: 2026-11-13

Quote & chart Expected move Insider trading IV rank history

VBIO headlines

latest coverage

Not much coverage yet. VBIO has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 2h ago

Valion Bio announces preferred stock and warrant sales totaling $4.77 million

General T3VBIO

Investing.com 1mo ago

Valion Bio regains Nasdaq minimum bid price compliance

Markets T3VBIO

Investing.com 2mo ago

Valion Bio appoints new COO, terminates CEO, and announces funding agreements

General T3VBIO

Investing.com 3mo ago

Sheba Medical Center to evaluate Valion Bio’s Entolimod in trial

General T3VBIO

Investing.com 4mo ago

Valion Bio issues preferred shares and warrants in $250,000 private placement

General T3VBIO

Seeking Alpha 5mo ago

Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work

General T2VBIO

Seeking Alpha News 5mo ago

Valion Bio Inc. (VBIO) Q1 2026 Earnings Call Prepared Remarks Transcript

Earnings T2VBIO

Investing.com 5mo ago

Form 13G Valion Bio For: 8 May

General T3VBIO

VBIO news alerts

Get an alert by email or push when a new headline mentions VBIO.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.